Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 1, 2021
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
Michelle Gilson Maintained (BMRN) at Strong Buy with Decreased Target to $91 on, Mar 1st, 2021
Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $95 to $91 on, Mar 1st, 2021.
Michelle has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Michelle's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michelle
- Joseph Schwartz of "SVB Leerink" Reiterated at Buy with Decreased Target to $108 on, Friday, November 6th, 2020
